Diaminomaleonitrile derivatives as new potential antichagasic compounds: a study of structure–activity relationships

Author:

de Oliveira Aldo S 12ORCID,S Mello Lucas dos3ORCID,H Ogihara Camila4,H Döring Thiago1ORCID,L Palomino-Salcedo David2ORCID,Michelan-Duarte Simone2ORCID,LG Ferreira Leonardo2ORCID,M Souza Julia2ORCID,Dávila-Rodríguez María José2ORCID,Cruz Júnior José W da1ORCID,R Dockal Edward3ORCID,D Andricopulo Adriano2ORCID

Affiliation:

1. Federal University of Santa Catarina, Campus of Blumenau, Department of Exact Sciences & Education, Rua João Pessoa, 2750, Velha, Blumenau – SC, 89036-256, Brazil

2. University of Sao Paulo, Laboratory of Medicinal & Computational Chemistry, Center for Research & Innovation in Biodiversity & Drug Discovery, Institute of Physics of São Carlos, Av. João Dagnone, 1100 - Santa Angelina, São Carlos, SP, 13563-120- Brazil

3. Federal University of São Carlos – UFSCar, Department of Chemistry, Laboratory of Inorganic Synthesis, Catalysis & Kinetics, Rodovia Washington Luis s/n Km 235, São Carlos, SP, Brazil

4. University of Campinas- UNICAMP, Chemistry institute, R. Josué de Castro, 126 - Cidade Universitária, Campinas, SP, Brazil

Abstract

Background: Schiff bases are synthetically accessible compounds that have been used in medicinal chemistry. Methods & results: In this work, 27 Schiff bases derived from diaminomaleonitrile were synthesized in high yields (80–98%). Molecular docking studies suggested that the Schiff bases interact with the catalytic site of cruzain. The most active cruzain inhibitor, analog 13 (IC50 = 263 nM), was predicted to form an additional hydrophobic contact with Met68 in the binding site of the enzyme. A strong correlation between the IC50 values and ChemScore binding energies was observed (R = 0.99). Kernel-based 2D quantitative structure–activity relationship models for the whole dataset yielded sound correlation coefficients (R2 = 0.844; Q2 = 0.719). Conclusion: These novel and potent cruzain inhibitors are worthwhile starting points in further Chagas disease drug discovery programs.

Publisher

Future Science Ltd

Subject

Drug Discovery,Pharmacology,Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3